WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, will participate in the Citizens Life Sciences Conference in New York on May 7, 2025.
At 11:00 a.m. ET, Kris Vaddi, Ph.D., CEO, Jane Huang, M.D., President and CMO, and Peggy Scherle, Ph.D., CSO, will join a fireside chat.
A live webcast will be available on the Company’s website under Events and Presentations and will remain archived for 90 days.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.